Harbour Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Harbour Investments’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.8K	Buy	1,139 +35	+3%	+$618	﹤0.01%	2882
2026 Q1	$18K	Buy	1,104 +1,096	+13,700%	+$18.3K	﹤0.01%	2955
2025 Q4	$138	Hold	8	–	–	﹤0.01%	3714
2025 Q3	$128	Hold	8	–	–	﹤0.01%	3622
2025 Q2	$102	Buy	8 +4	+100%	+$49	﹤0.01%	3512
2025 Q1	$51	Buy	+4	New	+$54	﹤0.01%	3499
2021 Q4	–	Sell	-652	Closed	-$14K	–	3096
2021 Q3	$14K	Buy	652 +13	+2%	+$278	﹤0.01%	2487
2021 Q2	$14K	Hold	639	–	–	﹤0.01%	2541
2021 Q1	$13K	Buy	+639	New	+$13.2K	﹤0.01%	2453

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Harbour Investments's HQL Position: Q2 2026 in Review

Harbour Investments increased its abrdn Life Sciences Investors (HQL) stake by 3.2% in Q2 2026, buying an estimated $618 and bringing the position to 1,139 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

Harbour Investments first reported a position in HQL in Q1 2021 and has held it in 9 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

Harbour Investments held 1,139 shares of abrdn Life Sciences Investors worth $22.8K as of Q2 2026.
Harbour Investments bought 35 abrdn Life Sciences Investors shares in Q2 2026, an estimated $618.
abrdn Life Sciences Investors made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2882 holding.
Harbour Investments first reported a position in abrdn Life Sciences Investors in Q1 2021 and has held it in 9 quarters since.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.